Second-line Treatment of Stage III/IV Non-Small-Cell Lung Cancer (NSCLC) with pemetrexed in routine clinical practice: Evaluation of performance status and health-related quality of life
© Schuette et al; licensee BioMed Central Ltd. 2011
Received: 8 June 2011
Accepted: 13 January 2012
Published: 13 January 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|8 Jun 2011||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|28 Jul 2011||Reviewed||Reviewer Report - alessandra bearz|
|31 Oct 2011||Reviewed||Reviewer Report - David Spigel|
|6 Dec 2011||Author responded||Author comments - Clemens Stoffregen|
|Resubmission - Version 3|
|6 Dec 2011||Submitted||Manuscript version 3|
|12 Dec 2011||Author responded||Author comments - Clemens Stoffregen|
|Resubmission - Version 4|
|12 Dec 2011||Submitted||Manuscript version 4|
|13 Jan 2012||Editorially accepted|
|13 Jan 2012||Article published||10.1186/1471-2407-12-14|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.